Abstract:BACKGROUND:TIPE3 (TNFAIP8L3), a transfer protein for lipid second messengers, is upregulated in human lung cancer tissues. The most popular lung cancer is non-small cell lung cancer (NSCLC) with high incidences and low survival rates, while the roles of TIPE3 in NSCLC remain largely unknown.METHODS:TIPE3 expression was examined in tissue chips from patients with NSCLC using immunohistochemistry; the correlation of plasma membrane expression of TIPE3 with T stage of NSCLC was analyzed. After endogenous TIPE3 was silenced via siRNA, or TIPE3 with N or C-terminal flag was overexpressed via transient or stable transfection, human NSCLC cells were assayed for the proliferation and migration, respectively. NSCLC cells, in which TIPE3 with C-terminal flag was stably transfected, were inoculated into mice to establish xenograft tumors, the tumor growth and the expression of TIPE3 in tumor tissues were examined.RESULTS:TIPE3 was broadly expressed in lung tissues of patients with NSCLC. The plasma membrane expression of TIPE3 was positively correlated with the T stage of NSCLC. Knockdown of endogenous TIPE3, which was predominantly expressed in the plasma membrane, inhibited the proliferation and migration of NSCLC cells. While transient overexpression of TIPE3 with N-terminal flag, which was mostly trapped in the cytoplasm, inhibited the growth and migration of NSCLC cells accompanied by inactivation of AKT and ERK. In contrast, stable overexpression of TIPE3 with C-terminal flag, which could be localized in the plasma membrane, markedly promoted the growth and migration of NSCLC cells through activation of AKT and ERK. Notably, in xenograft tumor models established with NSCLC cells, stable overexpression of TIPE3 with C-terminal flag in NSCLC cells significantly promoted the tumor growth and enhanced the expression and plasma membrane localization of TIPE3 in tumor tissues.CONCLUSION:This study demonstrates that human TIPE3 promotes the proliferation and migration of NSCLC cells depending on its localization on plasma membrane, whereas cytoplasmic TIPE3 may exert a negative function. Thus, manipulating the subcellular location of TIPE3 can be a promising strategy for NSCLC therapy.

Identical expression profiling of human and murine TIPE3 protein reveals links to its functions.

The Expression of Tipe1 in Murine Tissues and Human Cell Lines

The Unique Expression Profile of Human TIPE2 Suggests New Functions Beyond Its Role in Immune Regulation.

Tissue-specific expression of TIPE2 provides insights into its function.

Expression of TIPE family members in human colorectal cancer

The TIPE (TNFAIP8) family in inflammation, immunity, and cancer

TIPE3 Differentially Modulates Proliferation and Migration of Human Non-Small-cell Lung Cancer Cells Via Distinct Subcellular Location

TIPE2: A Candidate for Targeting Antitumor Immunotherapy.

TIPE1 function as a prognosis predictor and negative regulator of lung cancer

In Silico and in Vivo Analysis of TIPE1 Expression in Diffuse Large B Cell Lymphoma

Regulation of inflammation and tumorigenesis by the TIPE family of phospholipid transfer proteins

Regulatory Roles of Tumor Necrosis Factor-α-Induced Protein 8 Like-Protein 2 in Inflammation, Immunity and Cancers: A Review

Update in Immune Regulatory Pathway of Tumor Necrosis Factor-Α-induced Protein 8-Like 2

Tumor Necrosis Factor (Tnf)-Α-induced Protein 8-Like-2 (TIPE2) Inhibits Proliferation and Tumorigenesis in Breast Cancer Cells.

In Silico Analysis of Tumor Necrosis Factor Α-Induced Protein 8-Like-1 (TIPE1) Protein.

TIPE3 is the Transfer Protein of Lipid Second Messengers That Promote Cancer.

Clinical Significance of TIPE Expression in Gastric Carcinoma.

Understanding the roles of negative immune regulator TIPE2 in different diseases and tumourigenesis.

Expression of Tumor Necrosis Factor-Α Induced Protein 8 Like-2 Contributes to the Immunosuppressive Property of CD4+CD25+ Regulatory T Cells in Mice

TIPE3 Protein Promotes Breast Cancer Metastasis Through Activating AKT and NF-κB Signaling Pathways

TNFAIP8 protein functions as a tumor suppressor in inflammation-associated colorectal tumorigenesis